"Even in this time of uncertainty, Mayo Clinic is a place for hope and healing — and we're delivering the care you need. Mayo Clinic follows carefully designed, rigorously enforced safety precautions for anyone who needs face-to-face care. We're safely treating all patients, both in person and through virtual visits, in adherence with federal and state executive orders and guidance. Mayo Clinic provides expert care to everyone who needs healing. That means combining our comprehensive, integrated care with a seamless patient experience to provide exactly the care you need."

During the past decade, Thomas Osborn, MD conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Thomas Osborn, MD" are "Digital Ulcers" (2 trials) and "Systemic Sclerosis" (1 trials). Many other conditions were trialed in "Thomas Osborn, MD" in a lesser frequency.

Most popular intervention types in "Thomas Osborn, MD" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bosentan 125 mg" (2 trials), "Bosentan 62.5 mg" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Thomas Osborn, MD" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Thomas Osborn, MD". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Thomas Osborn, MD, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Thomas Osborn, MD, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".